Battling massive debt, craft beverage accelerator Mighty Craft (ASX: MCL) has been on a mission to divest its businesses to stay afloat. In keeping with that, the Company has signed a deal to sell the assets linked to Mismatch Brewing Company and The Hills Distillery (78 Degrees) to a third-party buyer, led by a consortium
Read More
The US’s sports betting landscape is under the scanner right now as one of its biggest athletes, Shohei Ohtani, tries to unravel himself from a sports betting scandal just months after signing a USD $700 million contract. The ongoing investigation is centred on a $6.9 million transaction from his bank account to an illicit betting
Read More
In Australia, enrolments in Higher Education have seen a 10% surge compared to 2019, driven by a surge in international students. In fact, about one in 40 Aussies is on a student or graduate visa. The demand is set to continue, putting the spotlight on online education marketplaces. AI-powered SaaS learning platform OpenLearning (ASX: OLL)
Read More
Neuroscience tech company Cogstate (ASX: CGS) has re-acquired the global rights to its technology previously exclusively licensed to Japanese pharma company and its global commercial partner, Eisai. The agreement excludes Japan and will come into effect on April 1, 2024. This marks an amendment to the duo’s 2020 agreement, which includes exclusivity across a few
Read More
Hospital care in the United States is set for greater digitisation with hospital services provided Inova Health expanding their Master Services Agreement with medtech company OneView Healthcare (ASX: ONE). Through the increasing transition towards digitisation of hospital services, gone are the nights of having nurses walk in and out of the room frequently throughout the
Read More
Parched for better financials going ahead, environmental intelligence technology company Envirosuite Limited (ASX: EVS) has announced that its EVS Water products will join the EVS Industrial portfolio. This decision follows EVS Water’s maturity milestone and the go-to-market and product synergies seen with the EVS Industrial portfolio, demonstrated through recent cross-sell wins and success in B2B
Read More
Medical software company Resonance Health (ASX: RHT) is set to target expansion into Japan through a collaboration agreement with medical imaging company Micron Inc in an effort to accelerate its sales growth in the country. Headquartered in Tokyo, Micron specialises in providing medical imaging support services to contract research organisations (CROs) and biopharmaceutical companies globally.
Read More
According to TechSci Research report, “Agroscience Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Agroscience Market stood at USD $35.94 billion in 2022 and is anticipated to grow with a CAGR of 7.12% in the forecast period, 2024-2028. This can be attributed to crop protection innovations. The need for effective
Read More
Australian pharmaceutical company Amplia Therapeutics (ASX: ATX) is conducting a clinical trial—the ACCENT trial—for pancreatic cancer. The trial will test a new drug called narmafotinib in combination with standard chemotherapy. Narmafotinib targets a protein called FAK (Focal Adhesion Kinase), which is becoming a hot area of research in cancer treatment. Amplia’s drug aims to make
Read More
Over 10% of Singaporean adults suffer from knee osteoarthritis, a progressive joint ailment, with a notable rise in cases among individuals aged 40 to 60. As per the Singapore General Hospital (SGH), knee preservation surgeries have doubled from 50 cases in 2020 to about 100 cases in 2021. Similarly, Vietnam experiences a surge in demand
Read More
